Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > August,02,2016
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(9)
•••
Post by richardtraderon Aug 03, 2016 1:29pm
99 Views
Post# 25106957

August,02,2016

August,02,2016
Date Symbol Name Short Volume Long Volume Total Volume Short%
2016-08-02 CXRX Concordia International 585004 365659 950663 62
2016-08-01 CXRX Concordia International 16630 27315 43945 38
2016-07-29 CXRX Concordia International 30590 6579 37169 82
2016-07-28 CXRX Concordia International 23198 9067 32265 72
2016-07-27 CXRX Concordia International 38098 56992 95090 40
2016-07-26 CXRX Concordia International 79959 77641 157600 51
2016-07-25 CXRX Concordia International 149989 69323 219312 68

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities